Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas
- PMID: 18026833
- DOI: 10.1007/s10549-007-9812-4
Expression of the forkhead transcription factor FOXP1 is associated with that of estrogen receptor-beta in primary invasive breast carcinomas
Abstract
We previously identified a correlation between estrogen receptor alpha (ERalpha) and the candidate tumour suppressor gene Forkhead Box P1 (FOXP1), whose nuclear protein expression in breast tumours was associated with improved patient survival. However, the expression pattern of FOXP1 in normal breast tissue is more reminiscent of the second receptor, ERbeta, which has an emerging role as a tumour suppressor in breast cancer and critically may underlie the ability of some ERalpha-negative tumours to respond to tamoxifen. In a series of 283 breast cancers, in which ERalpha-positive tumours were treated with tamoxifen, the nuclear expression of ERbeta correlated significantly with ERalpha (p = 0.004), low-tumour grade (p = 0.008) and nuclear FOXP1 (p = 0.01). High-grade tumours exhibited significantly more cytoplasmic ERbeta than the low-grade tumours (p = 0.006). Regression analysis demonstrated that FOXP1 expression was most closely related to nuclear ERbeta (p = 0.021). Neither, nuclear or cytoplasmic ERbeta expression demonstrated prognostic significance. FOXP1 is not estrogen regulated and silencing FOXP1 expression, using siRNA, did not affect ERalpha, ERbeta or progesterone receptor expression, suggesting ER and FOXP1 co-expression may reflect a common regulatory mechanism.
Similar articles
-
The expression and correlation between the transcription factor FOXP1 and estrogen receptors in epithelial ovarian cancer.Biochimie. 2015 Feb;109:42-8. doi: 10.1016/j.biochi.2014.12.001. Epub 2014 Dec 10. Biochimie. 2015. PMID: 25500588
-
Estrogen receptors in breast carcinogenesis and endocrine therapy.Mol Cell Endocrinol. 2015 Dec 15;418 Pt 3:240-4. doi: 10.1016/j.mce.2014.11.015. Epub 2014 Nov 26. Mol Cell Endocrinol. 2015. PMID: 25433206 Review.
-
FOXP1 and estrogen signaling in breast cancer.Vitam Horm. 2013;93:203-12. doi: 10.1016/B978-0-12-416673-8.00006-X. Vitam Horm. 2013. PMID: 23810008 Review.
-
FOXP1, an estrogen-inducible transcription factor, modulates cell proliferation in breast cancer cells and 5-year recurrence-free survival of patients with tamoxifen-treated breast cancer.Horm Cancer. 2011 Oct;2(5):286-97. doi: 10.1007/s12672-011-0082-6. Horm Cancer. 2011. PMID: 21901488 Free PMC article.
-
Expression of the forkhead box transcription factor FOXP1 is associated with oestrogen receptor alpha, oestrogen receptor beta and improved survival in familial breast cancers.J Clin Pathol. 2009 Oct;62(10):896-902. doi: 10.1136/jcp.2009.065169. Epub 2009 Jul 20. J Clin Pathol. 2009. PMID: 19622517
Cited by
-
Androgen and Estrogen β Receptor Expression Enhances Efficacy of Antihormonal Treatments in Triple-Negative Breast Cancer Cell Lines.Int J Mol Sci. 2024 Jan 25;25(3):1471. doi: 10.3390/ijms25031471. Int J Mol Sci. 2024. PMID: 38338747 Free PMC article.
-
Deacetylation of FOXP1 by HDAC7 potentiates self-renewal of mesenchymal stem cells.Stem Cell Res Ther. 2023 Jul 28;14(1):188. doi: 10.1186/s13287-023-03376-7. Stem Cell Res Ther. 2023. PMID: 37507770 Free PMC article.
-
Immunohistochemistry technique for effect of gold nanoparticles, laser, and photodynamic therapy on FoxP1 level in infected mice with mammary adenocarcinoma.Lasers Med Sci. 2023 Apr 19;38(1):106. doi: 10.1007/s10103-023-03765-7. Lasers Med Sci. 2023. PMID: 37074483
-
FOXP1 inhibits pancreatic cancer growth by transcriptionally regulating IRF1 expression.PLoS One. 2023 Mar 23;18(3):e0280794. doi: 10.1371/journal.pone.0280794. eCollection 2023. PLoS One. 2023. PMID: 36952469 Free PMC article.
-
Endometrial Cancer in Aspect of Forkhead Box Protein Contribution.Int J Environ Res Public Health. 2022 Aug 21;19(16):10403. doi: 10.3390/ijerph191610403. Int J Environ Res Public Health. 2022. PMID: 36012038 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials